| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Operating Officer
1 company
Hill Stephen J. serves as a Chief Operating Officer at LYEL. Across recent SEC filings that breaks down to 0 buys and 9 sells. Those positions are worth an estimated $261K at current prices.
Historically, Hill Stephen J.'s trades have earned a below-average insider score of 40/100 across 6 rated trades. On a 3-month view, 33.3% of the rated trades came out ahead, averaging -31.4% over three months.
The biggest single holding is LYEL (~$261K) as Chief Operating Officer. The recent filings there lean toward selling, a net 3,796 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 21, 2026 | LYEL Lyell Immunopharma, Inc. | Chief Operating Officer | Sell | 989 | $15.54 | $15,369.06 | -5.6% | - | - | |
| Aug 10, 2026 | LYEL Lyell Immunopharma, Inc. | Chief Operating Officer | Sell | 89 | $14.34 | $1,276.26 | -0.5% | - | - | |
| May 11, 2026 | LYEL Lyell Immunopharma, Inc. | Chief Operating Officer | Sell | 89 | $18.92 | $1,683.88 | -0.5% | -25.4% | - | |
| Feb 11, 2026 | LYEL Lyell Immunopharma, Inc. | Chief Operating Officer | Sell | 1,236 | $23.39 | $28,910.04 | -6.5% | -20.9% | - | |
| Feb 10, 2026 | LYEL Lyell Immunopharma, Inc. | Chief Operating Officer | Sell | 109 | $23.12 | $2,520.08 | -0.6% | -19.0% | - | |
| Nov 10, 2025 | LYEL Lyell Immunopharma, Inc. | Chief Operating Officer | Sell | 95 | $16.12 | $1,531.40 | -0.6% | +31.5% | - | |
| Aug 21, 2025 | LYEL Lyell Immunopharma, Inc. | Chief Operating Officer | Sell | 1,004 | $10.54 | $10,586.18 | -6.0% | +61.7% | +45.8% | |
| Aug 12, 2025 | LYEL Lyell Immunopharma, Inc. | Chief Operating Officer | Sell | 185 | $10.43 | $1,929.64 | -2.0% | +67.3% | +34.1% |